Opus Genetics Financial Overview
Opus Genetics's market cap is currently $138.62M. The company's EPS TTM is $-0.25; its P/E ratio is -1.17; Opus Genetics is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
